Daily
The next COVID challenge – mass immunisation
In the last few days, Pfizer BioNTech a German-US company, and the US company Moderna have separately announced that that the COVID-19 vaccines they have been developing have proved ninety-five per cent effective.
The article The next COVID challenge – mass immunisation appeared first on Stabroek News.
